# FDA Inspection 978214 - Eversight - July 27, 2016

Source: https://www.keypedia.com/records/fda_inspections/eversight/8bb74978-4a63-4a99-900c-3e983f3de64a
Source feed: FDA_Inspections

> FDA Inspection 978214 for Eversight on July 27, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 978214
- Company Name: Eversight
- Inspection Date: 2016-07-27
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1192811 - 2022-12-05](https://www.keypedia.com/records/fda_inspections/eversight/b32a36d3-b859-430e-8bf2-a933718795fd)
- [FDA Inspection 1192811 - 2022-12-05](https://www.keypedia.com/records/fda_inspections/eversight/e24e47aa-9d49-4bbe-b2fe-1ec27b87e5ed)
- [FDA Inspection 1192811 - 2022-12-05](https://www.keypedia.com/records/fda_inspections/eversight/a563e7dd-9148-4889-b44f-309d354cff07)
- [FDA Inspection 1084752 - 2019-03-25](https://www.keypedia.com/records/fda_inspections/eversight/bf81798b-a525-489a-b224-43f14f8b69d9)
- [FDA Inspection 1084752 - 2019-03-25](https://www.keypedia.com/records/fda_inspections/eversight/156736b8-83b8-4827-b754-ef4b5dd288a2)

Company: https://www.keypedia.com/companies/eversight/8a3771b5-4d35-46b0-bf77-1d20d0c197d3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d